E., G., Y., W., Y., L., J., H., S., T., M., W., . . . C., A. (2017). Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B.
Chicago Style CitationE., Gane, et al. Efficacy and Safety of Prolonged 3-year Telbivudine Treatment in Patients With Chronic Hepatitis B. 2017.
MLA CitationE., Gane, et al. Efficacy and Safety of Prolonged 3-year Telbivudine Treatment in Patients With Chronic Hepatitis B. 2017.
Warning: These citations may not always be 100% accurate.